Israeli study shows 4th shot of Covid-19 vaccine less effective on Omicron
India TodayA fourth shot of Covid-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a preliminary study in Israel. Israel's Sheba Medical Center has given second booster shots in a trial among its staff and is studying the effect of the Pfizer booster in 154 people after two weeks and the Moderna booster in 120 people after one week, said Gili Regev-Yochay, director of the Infectious Diseases Unit. "We know by now that the level of antibodies needed to protect and not to got infected from Omicron is probably too high for the vaccine, even if it's a good vaccine." Israel was the fastest country to roll out initial vaccinations against Covid-19 a year ago and last month started offering a fourth shot, or a second booster, to the most vulnerable and high-risk groups.